News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wendel Bruce
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Wendel Bruce (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Bought 3,268 shares
@ $3.14, valued at
$10.3k
Bought 1,374 shares
@ $8.87, valued at
$12.2k
Bought 441 shares
@ $8.73, valued at
$3.8k
Granted 347,572 shares
@ $0
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
| 10/07/2021 |
3
| Wendel Bruce (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 06/18/2020 |
4
| Wendel Bruce (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.77, valued at
$44.3k
|
|
| 06/25/2019 |
4
| Wendel Bruce (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.81, valued at
$45.3k
|
|
| 02/13/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Wendel Bruce (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.09, valued at
$52.3k
|
|
| 06/16/2016 |
4
| Wendel Bruce (Director) has filed a Form 4 on Verastem, Inc. |
| 06/16/2016 |
3
| Wendel Bruce (Director) has filed a Form 3 on Verastem, Inc. |
| 10/19/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Disposed/sold 119,784 shares
@ $0
Disposed/sold 138,125 options to buy
@ $39.93, valued at
$5.5M
Disposed/sold 10,607 options to buy
@ $65.73, valued at
$697.2k
Disposed/sold 4,242 options to buy
@ $72.02, valued at
$305.5k
Disposed/sold 2,121 options to buy
@ $70.63, valued at
$149.8k
Disposed/sold 3,678 options to buy
@ $64.99, valued at
$239k
|
|
| 03/17/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Granted 74,375 shares
@ $0
Granted 138,125 options to buy
@ $39.93, valued at
$5.5M
|
|
| 03/03/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Paid exercise price by delivering 367 shares
@ $32.67, valued at
$12k
|
|
| 01/26/2010 |
4
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Paid exercise price by delivering 239 shares
@ $41.17, valued at
$9.8k
|
|
| 12/18/2009 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 12/18/2009 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/12/2009 |
4
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Sold 797 shares
@ $35.42, valued at
$28.2k
|
|
| 03/03/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2009 |
4/A
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc. |
| 02/05/2009 |
4
| Wendel Bruce (Exec. VP Corporate Development) has filed a Form 4 on Abraxis BioScience, Inc. |
|
|